Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients.

Mascheretti S, Hinrichsen H, Ross S, Buggisch P, Hampe J, Foelsch UR, Schreiber S.

Clin Exp Immunol. 2004 May;136(2):328-33.

2.

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.

Promrat K, McDermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, Merrell M, Soza A, Heller T, Ghany M, Park Y, Alter HJ, Hoofnagle JH, Murphy PM, Liang TJ.

Gastroenterology. 2003 Feb;124(2):352-60. Erratum in: Gastroenterology. 2003 Apr;124(4):1168..

PMID:
12557141
3.

CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan.

Konishi I, Horiike N, Hiasa Y, Michitaka K, Onji M.

Intervirology. 2004;47(2):114-20.

PMID:
15192276
4.

The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.

Goulding C, McManus R, Murphy A, MacDonald G, Barrett S, Crowe J, Hegarty J, McKiernan S, Kelleher D.

Gut. 2005 Aug;54(8):1157-61. Epub 2005 Apr 29. Erratum in: Gut. 2005 Oct;54(10):1508. McManus, R [added].

5.

Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.

Breunis WB, Biezeveld MH, Geissler J, Kuipers IM, Lam J, Ottenkamp J, Hutchinson A, Welch R, Chanock SJ, Kuijpers TW.

Clin Exp Immunol. 2007 Oct;150(1):83-90. Epub 2007 Aug 2.

6.

Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection.

Ksiaa Cheikh Rouhou L, Gorgi YL, Skhiri HA, Aouadi H, Ayed SJ, Sfar I, Ayed K, Ben Abdallah T.

Arab J Nephrol Transplant. 2011 Sep;4(3):117-24.

PMID:
22026334
8.

Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.

Bogner JR, Lutz B, Klein HG, Pollerer C, Troendle U, Goebel FD.

HIV Med. 2004 Jul;5(4):264-72.

9.

Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.

Hellier S, Frodsham AJ, Hennig BJ, Klenerman P, Knapp S, Ramaley P, Satsangi J, Wright M, Zhang L, Thomas HC, Thursz M, Hill AV.

Hepatology. 2003 Dec;38(6):1468-76.

PMID:
14647058
10.

[Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].

Wasik TJ, Smoleń J, Kruszyński P, Bratosiewicz-Wasik J, Beniowski M.

Wiad Lek. 2005;58(9-10):500-7. Polish.

PMID:
16529059
11.

Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects.

Viladés C, Broch M, Plana M, Domingo P, Alonso-Villaverde C, Pedrol E, Knobel H, Dalmau D, Peraire J, Gutiérrez C, López A, Sambeat MA, Olona M, Garcia F, Richart C, Gatell JM, Vidal F; Chemokines and Long-Term Nonprogressors Study Group.

J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):132-8.

PMID:
17091019
12.

Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians.

Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, Gupta R, Thelma BK.

BMC Med Genet. 2007 Apr 12;8:20.

13.

Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection.

Beinhardt S, Aberle JH, Strasser M, Dulic-Lakovic E, Maieron A, Kreil A, Rutter K, Staettermayer AF, Datz C, Scherzer TM, Strassl R, Bischof M, Stauber R, Bodlaj G, Laferl H, Holzmann H, Steindl-Munda P, Ferenci P, Hofer H.

Gastroenterology. 2012 Jan;142(1):78-85.e2. doi: 10.1053/j.gastro.2011.09.039. Epub 2011 Sep 24.

PMID:
22192885
14.

Genetic variations in CC chemokine receptors and hypertension.

Zhang M, Ardlie K, Wacholder S, Welch R, Chanock S, O'Brien TR.

Am J Hypertens. 2006 Jan;19(1):67-72.

PMID:
16461193
15.

Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population.

Rebbani K, Ezzikouri S, Marchio A, Ababou M, Kitab B, Dejean A, Kandil M, Pineau P, Benjelloun S.

Infect Genet Evol. 2014 Aug;26:1-7. doi: 10.1016/j.meegid.2014.04.019. Epub 2014 May 4.

PMID:
24797387
16.

Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C.

Grünhage F, Nattermann J, Gressner OA, Wasmuth HE, Hellerbrand C, Sauerbruch T, Spengler U, Lammert F.

J Hepatol. 2010 Feb;52(2):153-9. doi: 10.1016/j.jhep.2009.11.001. Epub 2009 Nov 27.

PMID:
20044164
17.

CCR5 and CCR2 gene polymorphisms in hypertensive patients.

Mettimano M, Specchia ML, Ianni A, Arzani D, Ricciardi G, Savi L, Romano-Spica V.

Br J Biomed Sci. 2003;60(1):19-21.

PMID:
12680626
18.

Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction.

González P, Alvarez R, Batalla A, Reguero JR, Alvarez V, Astudillo A, Cubero GI, Cortina A, Coto E.

Genes Immun. 2001 Jun;2(4):191-5.

19.

IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.

Rao HY, Sun DG, Jiang D, Yang RF, Guo F, Wang JH, Liu F, Zhang HY, Zhang HH, Du SC, Jin Q, Qin H, Lok AS, Wei L.

J Viral Hepat. 2012 Mar;19(3):173-81. doi: 10.1111/j.1365-2893.2011.01497.x. Epub 2011 Aug 4.

PMID:
22329371
20.

Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.

O'Brien TR, McDermott DH, Ioannidis JP, Carrington M, Murphy PM, Havlir DV, Richman DD.

AIDS. 2000 May 5;14(7):821-6.

PMID:
10839590

Supplemental Content

Support Center